FORTERRE GAEL (Chief Commercial Officer) received a stock award from VOLITIONRX LTD
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/23/2026ACC: 0001477932-26-000371
Officer· Chief Commercial Officer
Since Feb 2021
+38.10K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
38.10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+38.10K
Price / share
—
Trade value
—
% of position
24.8%
—
153.78K→191.88K
Total
Net shares
+38.10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | A · Award | +38.10K | — | — | 24.8% | 153.78K | 191.88K |
| Total | +38.10K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned32.50K
Common Stock
IndirectShares owned5K
Total
37.50K indirect37.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 32.50K | Indirect |
| Common Stock | 5K | Indirect |
| Total | 37.50K | 37.50K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported